[MO2] Mini-Oral Session 2　Hepatobiliary / Pancreatic Cancer 1（Pancreatic Cancer 1）
【E】

[MO2-5] Homologous recombination repair-related genes in pancreatic cancer and oxaliplatin-based chemotherapy: prospective study

^○Tomohiro Kondo¹, Daisuke Yamaguchi², Junichi Matsubara¹, Takashi Ura³, Motoo Nomura¹, Taro Funakoshi¹, Akira Yokoyama¹, Keitaro Doi¹, Masashi Tamaoki¹, Tadayuki Kou⁴, Toshinao Itani⁵, Michio Yoshimura⁶, Norimitsu Uza⁷, Takahiro Yamada⁸, Toshihiko Masui⁹, Sachiko Minamiguchi¹⁰, Hideki Ishikawa¹¹, Shigemi Matsumoto¹, Manabu Muto¹, Masashi Kanai¹ (1.Department of Clinical Oncology, Kyoto University Hospital, 2.Department of Medical Oncology, Kyoto-Katsura Hospital, 3.Department of Clinical Oncology, National Hospital Organization Kyoto Medical Center, 4.Department of Gastroenterology and Hepatology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, 5.Department of Gastroenterology, Kobe City Nishi-Kobe Medical Center, 6.Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 7.Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 8.Clinical Genetics Unit, Kyoto University Hospital, 9.Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 10.Department of Diagnostic Pathology, Kyoto University Hospital, 11.Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine)